Treating depression with selective serotonin reuptake inhibitors: A practical approach

Shirlene M. Sampson

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations


Depression is a common disorder that is becoming better understood as an illness that can be chronic, recurrent, and refractory to treatment. Depression can produce substantial suffering and profoundly affect a patient's self-esteem, relationships, and functional capacity. The improved adverse-effect profile and safety from overdose of selective serotonin reuptake inhibitors (SSRIs) have led to treatment of milder forms of depression and thus increased treatment of depression overall. This article synthesizes several previously published reviews and psychopharmacology resources and addresses practical issues related to initiating, monitoring, continuing, and discontinuing SSRIs. Precautions related to SSRI use and important considerations for various types of depression are discussed.

Original languageEnglish (US)
Pages (from-to)739-744
Number of pages6
JournalMayo Clinic proceedings
Issue number7
StatePublished - 2001

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Treating depression with selective serotonin reuptake inhibitors: A practical approach'. Together they form a unique fingerprint.

Cite this